In The News

• 30

  Oct

  Singapore infrastructure a draw for pharma giants

  The Business Times by MARC O'DONOGHUE

  IN 50 YEARS, Singapore has undergone significant transformation from a developing country into a thriving metropolis. Today, with its robust physical and regulatory environment, global connectivity and skilled talent pool, this city-state is a multidisciplinary… More

• 29

  Oct

  J&J drug unit to leverage Singapore's biotech hub

  The Business Times by ANNABETH LEOW

  Singapore JOHNSON & Johnson's (J&J) regional pharmaceutical head believes that Singapore offers innovation, research and development tie-up opportunities, even as wider insurance coverage in the Asia-Pacific is expected to fuel growth for drugmakers.… More

• 25

  Oct

  For pharma, volatility and value are two sides of the same coin

  The Business Times by ANNABETH LEOW

  Singapore FOR the four months to July, Singapore's export-oriented drug industry notched up double-digit yearly growth, while July exports surged a stunning 109 per cent - yet industry players are hard put to forecast a consistent trajectory. Rather,… More